Predominant polarity in bipolar disorder and validation of the polarity index in a German sample

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Volkert, Julia ^a,b   Zierhut, Kathrin C ^a   Schiele, Miriam A ^a   Wenzel, Martina ^a   Kopf, Juliane ^b   Kittel Schneider, Sarah ^b   Reif, Andreas ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Bipolar disorder; Depression; EBM; Maintenance treatment; Mania; Polarity index; Predominant polarity

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; PREGABALIN; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZIPRASIDONE; ANTIDEPRESSANT AGENT; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; TRIAZINE DERIVATIVE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DEPRESSIVE PREDOMINANT POLARITY; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; FEMALE; GERMANY; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC PREDOMINANT POLARITY; POLARITY INDEX; POLYPHARMACY; RETROSPECTIVE STUDY; ADOLESCENT; ANALYSIS OF VARIANCE; ETHNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX; STANDARDS; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; FEMALE; GERMANY; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRIAZINES; VALPROIC ACID; YOUNG ADULT;

EID: 84924089943     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0322-8     Document Type: Article

References (26)

1. Perlis RH, Delbello MP, Miyahara S, Wisniewski SR, Sachs GS, Nierenberg AA: Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants. Biol Psychiatr 2005, 58(7):549-553.
2. Daban C, Colom F, Sanchez-Moreno J, Garcia-Amador M, Vieta E: Clinical correlates of first-episode polarity in bipolar disorder. Compr Psychiatr 2006, 47(6):433-437.
3. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg J, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vàzquez G, Perlis RH, Ketter TA, et al: The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatr 2013, 170(11):1249-1262.
4. Colom F, Vieta E, Daban C, Pacchiarotti I, Sanchez-Moreno J: Clinical and therapeutic implications of predominant polarity in bipolar disorder. Affect Disord 2006, 93(1-3):13-17.
5. Baldessarini RJ, Undurraga J, Vazquez GH, Tondo L, Salvatore P, Ha K, Khalsa HM, Lepri B, Ha TH, Chang JS, Tohen M, Vieta E: Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand 2012, 125(4):293-302.
6. Carvalho AF, McIntyre RS, Dimelis D, Gonda X, Berk M, Nunes-Neto PR, Cha DS, Hyphantis TN, Angst J, Fountoulakis KN: Predominant polarity as a course specifier for bipolar disorder: a systematic review. Affect Disord 2014, 163:56-64.
7. Gonzalez-Pinto A, Alberich S, Barbeito S, Alonso M, Vieta E, Martinez-Aran A, Saenz M, Lopez P: Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study. Affect Disord 2010, 124(3):250-255.
8. Vieta E, Berk M, Wang W, Colom F, Tohen M, Baldessarini RJ: Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. Affect Disord 2009, 119(1-3):22-27.
9. Rosa AR, Andreazza AC, Kunz M, Gomes F, Santin A, Sanchez-Moreno J, Reinares M, Colom F, Vieta E, Kapczinski F: Predominant polarity in bipolar disorder: diagnostic implications. Affect Disord 2008, 107(1-3):45-51.
10. Goodwin GM, Consensus Group of the British Association for P: Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009, 23(4):346-388.
11. Colom F, Vieta E: The road to DSM-V. Bipolar disorder episode and course specifiers. Psychopathology 2009, 42(4):209-218.
12. Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M: The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009, 11(5):453-473.
13. Association AP: Diagnostic and Statistical Manual of Mental Disorders (5th Ed.). Arlington: VA: American Psychiatric Publishing; 2013.
14. Popovic D, Reinares M, Goikolea JM, Bonnin CM, Gonzalez-Pinto A, Vieta E: Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol 2012, 22(5):339-346.
15. Popovic D, Torrent C, Goikolea JM, Cruz N, Sanchez-Moreno J, Gonzalez-Pinto A, Vieta E: Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study. Acta Psychiatr Scand 2013, 129(5):366-374.
16. Popovic D, Reinares M, Amann B, Salamero M, Vieta E: Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder. Psychopharmacology 2011, 213(4):657-667.
17. Popovic D, Reinares M, Scott J, Nivoli A, Murru A, Pacchiarotti I, Vieta E, Colom F: Polarity index of psychological interventions in maintenance treatment of bipolar disorder. Acta Psychiatr Scand 2013, 82(5):292-298.
18. Association AP: Diagnostic and Statistical Manual of Mental Disorders (4th Ed., Text Rev.). Washington: DC: Author; 2000.
19. Wittchen HUW U, Gruschwitz S, Zaudig M: SKID-I: Strukturiertes Klinisches Interview für DSM-IV, Achse 1: Psychische Störungen. Interviewheft. Göttingen: Hogrefe; 1997.
20. Rucker J, Newman S, Gray J, Gunasinghe C, Broadbent M, Brittain P, Baggaley M, Denis M, Turp J, Stewart R, Lovestone S, Schumann G, Farmer A, McGuffin P: OPCRIT+: an electronic system for psychiatric diagnosis and data collection in clinical and research settings. Br J Psychiatr 2011, 199(2):151-155.
21. Henry C, Etain B: New ways to classify bipolar disorders: going from categorical groups to symptom clusters or dimensions. Curr Psychiatr Rep 2010, 12(6):505-511.
22. Calabrese JR, Vieta E, El-Mallakh R, Findling RL, Youngstrom EA, Elhaj O, Gajwani P, Pies R: Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatr 2004, 56(12):957-963.
23. Nivoli AM, Pacchiarotti I, Rosa AR, Popovic D, Murru A, Valenti M, Bonnin CM, Grande I, Sanchez-Moreno J, Vieta E, Colom F: Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. Affect Disord 2011, 133(3):443-449.
24. Pfennig A, Bschor T, Baghai T, Braunig P, Brieger P, Falkai P, Geissler D, Gielen R, Giesler H, Gruber O, Kopp I, Meyer TD, Möhrmann KH, Muche-Borowski C, Padberg F, Scherk H, Strech D, Bauer M: S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations. Nervenarzt 2012, 83(5):568-586.
25. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013, 15(1):1-44.
26. Vazquez GH, Tondo L, Undurraga J, Baldessarini RJ: Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol 2013, 16(7):1673-1685.